|
National Stock Number(NSN): 6505-00-200-1641 (6505002001641, 002001641)
| NIIN: |
00-200-1641 |
Item Name: |
NITROFURANTOIN CAPSULES1 |
INC: |
30117
|
| FSC: |
6505
|
Assignment Date: |
Mar-28-1973 |
CRIT: |
N |
IIG: |
30117 |
| ISC: |
2 |
Date Standardized: |
Nov-11-1978 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Dec-01-1999 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
70705 |
04489
|
NORWICH EATON PHARMACEUTICALS INC PROFESSIONAL PRODUCTS SUB OF PROCTER AND GAMBLE CO |
H |
3 |
2 |
4 |
57 |
3 |
D |
|
|
|
|
|
70705 |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
3 |
2 |
4 |
57 |
|
D |
|
|
|
|
|
MACRODANTIN |
04489
|
NORWICH EATON PHARMACEUTICALS INC PROFESSIONAL PRODUCTS SUB OF PROCTER AND GAMBLE CO |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
MACRODANTIN |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00149-0007-05 |
04489
|
NORWICH EATON PHARMACEUTICALS INC PROFESSIONAL PRODUCTS SUB OF PROCTER AND GAMBLE CO |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NDC00149-0007-05 |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
Z |
M |
U |
1 |
A |
$58.69 |
BT |
|
C2201X- |
Apr-01-1998 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$58.69 |
BT |
|
------- |
Apr-01-1998 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$58.69 |
BT |
|
9L----- |
Apr-01-1998 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$58.69 |
BT |
|
------- |
Apr-01-1998 |
H |
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
25.000 MILLIGRAMS NITROFURANTOIN ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
HARD |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
144 |
| FEAT |
SPECIAL FEATURES |
MACRONIZED CRYSTALS |
| PKQT |
INTERMEDIATE PACKAGE QUANTITY |
12 |
| SUCB |
UNIT OF ISSUE CUBE |
0.005 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.12 POUNDS |
| THPE |
THERAPEUTIC EQUIVALENT |
MACRODANTIN BY NORWICH-EATON |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Nov-28-1998 |
3 |
H |
|
|
|
|
| FSKX |
|
Nov-28-1998 |
3 |
H |
|
|
|
|
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
| N9LM |
|
Nov-28-1998 |
3 |
H |
|
|
|
|
| YK01 |
|
Apr-01-1991 |
|
|
|
|
YK |
YK |
|